Evidence map›Paper›PMID 39349545›Full record

ArticleScientific reports2024

Murine neonatal cardiac regeneration depends on Insulin-like growth factor 1 receptor signaling.

Thomas Schuetz, Theresa Dolejsi, Eva Beck, Fabio Fugger, Alexander Bild, Marie-Theres Duin, Jasmina Gavranovic-Novakovic, Erika Hilbold, Thomas Hoffmann, Johannes Zuber and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Thomas Schuetz *Department of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Theresa Dolejsi *Department of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Eva BeckDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Fabio FuggerDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Alexander BildDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Marie-Theres DuinDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Jasmina Gavranovic-NovakovicDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Erika HilboldInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.
Thomas HoffmannInstitute of Molecular Pathology (IMP), Vienna, Austria.
Johannes ZuberInstitute of Molecular Pathology (IMP), Vienna, Austria.
Axel BauerDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria.
Frank RuschitzkaCenter for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Christian BärInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.
Josef Martin PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria. josef.penninger@helmholtz-hzi.de.
Bernhard Johannes HaubnerDepartment of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, Innsbruck, Austria. bernhard.haubner@usz.ch.

Funding

Austrian Science Fund I 4161-BBundesministerium für Bildung und Forschung 01KL1903Bundesministerium für Bildung und Forschung 01KX2324Canada 150 Research Chairs Program F18-01336Fondation Leducq 21CVD03Medizinische Universität Innsbruck 2017-01-014
6 · The paper itself

Abstract

Unlike adult mammals, the hearts of neonatal mice possess the ability to completely regenerate from myocardial infarction (MI). This observation has sparked vast interest in deciphering the potentially lifesaving and morbidity-reducing mechanisms involved in neonatal cardiac regeneration. In mice, the regenerative potential is lost within the first week of life and coincides with a reduction of Insulin-like growth factor 1 receptor (Igf1r) expression in the heart. Igf1r is a well-known regulator of cardiomyocyte maturation and proliferation in neonatal mice. To test the role of Igf1r as a pivotal factor in cardiac regeneration, we knocked down (KD) Igf1r specifically in cardiomyocytes using recombinant adeno-associated virus (rAAV) delivery and troponin T promotor driven shRNAmirs. Cardiomyocyte specific Igf1r KD versus control mice were subjected to experimental MI by permanent ligation of the left anterior descending artery (LAD). Cardiac functional and morphological data were analyzed over a 21-day period. Neonatal Igf1r KD mice showed reduced systolic cardiac function and increased fibrotic cardiac remodeling 21 days post injury. This cardiac phenotype was associated with reduced cardiomyocyte nuclei mitosis and decreased AKT and ERK phosphorylation in Igf1r KD, compared to control neonatal mouse hearts. Our in vivo murine data show that Igf1r KD shifts neonatal cardiac regeneration to a more adult-like scarring phenotype, identifying cardiomyocyte-specific Igf1r signaling as a crucial component of neonatal cardiac regeneration.

Indexed as

Animals, NewbornMyocardial InfarctionMyocytes, CardiacReceptor, IGF Type 1RegenerationSignal TransductionAnimalsHeartInsulin-Like PeptidesMiceIgf1r protein, mouseInsulin-Like PeptidesReceptor, IGF Type 1Insulin-like growth factor 1 receptorLAD ligationMyocardial infarctionNeonatal cardiac regeneration

Identifiers

PMID39349545
PMCPMC11443045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.